MEPOLIZUMAB and DYSPNOEA

10,201 reports of this reaction

5.9% of all MEPOLIZUMAB reports

#2 most reported adverse reaction

Overview

DYSPNOEA is the #2 most commonly reported adverse reaction for MEPOLIZUMAB, manufactured by GlaxoSmithKline LLC. There are 10,201 FDA adverse event reports linking MEPOLIZUMAB to DYSPNOEA. This represents approximately 5.9% of all 173,706 adverse event reports for this drug.

Patients taking MEPOLIZUMAB who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA10,201 of 173,706 reports

DYSPNOEA is moderately reported among MEPOLIZUMAB users, representing a notable but not dominant share of adverse events.

Other Side Effects of MEPOLIZUMAB

In addition to dyspnoea, the following adverse reactions have been reported for MEPOLIZUMAB:

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

0XYGENABEMACICLIBABIRATERONE ACETATEACALABRUTINIBACETAMINOPHENACETAMINOPHEN 325 MGACETAMINOPHEN 325MGACETAMINOPHEN 500 MGACETAMINOPHEN 500MGACETAMINOPHEN AND CODEINE PHOSPHATEACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDEACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE

Frequently Asked Questions

Does MEPOLIZUMAB cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 10,201 FDA reports for MEPOLIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with MEPOLIZUMAB?

DYSPNOEA accounts for approximately 5.9% of all adverse event reports for MEPOLIZUMAB, making it one of the most commonly reported side effect.

What should I do if I experience DYSPNOEA while taking MEPOLIZUMAB?

If you experience dyspnoea while taking MEPOLIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

MEPOLIZUMAB Full ProfileAll Drugs Causing DYSPNOEAGlaxoSmithKline LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.